2024 Somalogic stock - When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. These are fundamentally strong and non-speculative stocks that are under $10 Since the meme stock euphoria in 2020, i...

 
BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire .... Somalogic stock

A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.SomaLogic's stock was trading at $0.40 on January 1st, 2023. Since then, SLGCW shares have decreased by 65.0% and is now trading at $0.14. View the best growth stocks for 2023 here. This page (NASDAQ:SLGCW) was last updated on 10/12/2023 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.The custom stock SOMAmer solutions for 10%, ... SomaLogic has filed patent applications on aspects of this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Funding: This work was funded by SomaLogic. SomaLogic had no role in the original prospective CKD study.Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors SomaLogic Inc (NASDAQ: SLGC)’s stock price has gone rise by 4.09 in comparison to its previous close of 2.20, however, the company has experienced a 5.77% increase in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-31 that BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a …Why SomaLogic Stock Dived by 10% on Wednesday The market wasn't impressed by the company's announced tie-up with Standard BioTools. Eric Volkman | Oct 4, 2023Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger (“Effective Time”), each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 shares of Common Stock.SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?SomaLogic, Inc. (76X0.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock SomaLogic, Inc. | Börse Stuttgart: 76X0 | Börse StuttgartPlanned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …--SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023. ... Common stock, $0.0001 par value; ...Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy statement/prospectus, SomaLogic’s proxy statement for its 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 25, 2023, Current Reports on Form …SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in …of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited …SomaLogic Stock Earnings. The value each SLGC share was expected to gain vs. the value that each SLGC share actually gained. SomaLogic ( SLGC) reported Q2 2023 earnings per share (EPS) of -$0.13, beating estimates of -$0.14 by 6.95%. In the same quarter last year, SomaLogic 's earnings per share (EPS) was -$0.13.In conjunction with the announcement, Standard Bio raised its full-year guidance to $100M–$105M, while SomaLogic reaffirmed its 2023 guidance at $80M–$84M. More on Standard Bio, SomaLogic, etc.Standard BioTools, SomaLogic to Merge. Oct 04, 2023 | staff reporter. Save for later. NEW YORK – Standard BioTools, formerly known as Fluidigm, and SomaLogic said on Wednesday that they will merge in an all-stock deal to create a company worth over $1 billion.Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November ...SomaLogic and Standard BioTools have agreed to combine in an all-stock merger. The companies said Wednesday that the tie-up would create a diversified leader in life sciences tools with a pro ...Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited CLIA laboratory.SLGC | Complete SomaLogic Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.SomaLogic common stock is traded on the Nasdaq exchange under the symbol SLGC, and SomaLogic warrants are traded on the Nasdaq under the symbol SLGCW. Does SomaLogic pay dividends? SomaLogic does not expect to declare or pay any cash or other dividends on its common stock.Incentive Stock Option Agreement 2009 Equity Incentive Plan SomaLogic, Inc. (the “Company”), pursuant to its 2009 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock to you, the Optionee named below.Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite.Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. If SomaLogic Opco fails to make the Final Payment as and when due, interest shall thereafter accrue at a rate of 12% per annum until it is paid. Under the terms of the Leases, SomaLogic Opco was required to deliver a letter of credit in the amount of approximately $2,000,000 for each of Lease 1 and Lease 2 to secure the obligations …SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Stocks United States SLGC Overview Stock Screener Earnings Calendar Sectors Nasdaq | SLGC U.S.: Nasdaq SomaLogic Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 15, 2023... Get the latest Somalogic Inc (SLGC) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23.SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ...Under the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, SomaLogic …Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …Nov 17, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ... Nov 30, 2023 · A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The custom stock SOMAmer solutions for 10%, ... SomaLogic has filed patent applications on aspects of this work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Funding: This work was funded by SomaLogic. SomaLogic had no role in the original prospective CKD study.3 the extension and one for the amplification step. Together, these internal controls monitor each step in the PEA protocol. Triplicates of an external negative control sample and a plate control sampleHe currently serves as Chairman of SomaLogic, a company that he founded and formerly served as CEO. ... The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …NEW YORK – Standard BioTools, formerly known as Fluidigm, and SomaLogic said on Wednesday that they will merge in an all-stock deal to create a company worth over $1 billion. Under the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, …Somalogic Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Why SomaLogic Stock Dived by 10% ...What is the target price for SomaLogic (SLGC) stock? The latest price target for SomaLogic ( NASDAQ: SLGC) was reported by Jefferies on Thursday, October 5, 2023. The analyst firm set a price ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsView SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.View Your Watchlist. Stock analysis for SomaLogic Inc (SLGC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and …Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Standard BioTools Inc. and SomaLogic, Inc. is fair to Standard BioTools shareholders. Under the terms of the...Mar 28, 2023 · SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ... The ownership percentages with respect to the post-combination company following the Business Combination and PIPE Investment are based on aggregate Merger Consideration of 125,000,000 shares of CMLS II Class A Common Stock (assuming no cash elections will be made by SomaLogic stockholders) and assume 116,013,417 shares will be issued at ...SomaLogic, Inc. Warrant (SLGCW) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Oct 5, 2023 · SomaLogic ( SLGC) and Standard BioTools ( LAB) announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 ... The ETF added to its position in the biotech stock earlier this month and now owns nearly 12.6 million shares, valued at close to $29 million. SomaLogic is a pioneer in proteomics, the study of ...Historical daily share price chart and data for SomaLogic since 2021 adjusted for splits and dividends. The latest closing stock price for SomaLogic as of November 29, 2023 is …SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels ...Incentive Stock Option Agreement 2009 Equity Incentive Plan SomaLogic, Inc. (the “Company”), pursuant to its 2009 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock to you, the Optionee named below.Somalogic Inc stock performance at a glance. Check Somalogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Founders David Brunel, Larry Gold. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name SomaLogic, Inc. Stock Symbol FRA:76X0. Company Type For Profit. Contact Email [email protected]. Phone Number 303-625-9000. SomaLogic operates as a protein biomarker discovery and clinical diagnostics company.Stock analysis for SomaLogic Inc (CMII:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance …of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited …Stock analysis for SomaLogic Inc (CMII:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year OutlookView SomaLogic, Inc SLGC investment & stock information. Get the latest SomaLogic, Inc SLGC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Sep 1, 2021 · Following the transaction, the combined company was renamed SomaLogic, Inc., and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on September 2 ... SomaLogic, Inc. (NasdaqGM:SLGC) entered into a definitive agreement to acquire to acquire Standard BioTools Inc. (NasdaqGS:LAB) from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP, managed by Viking Global Investors LP and others for approximately $570 million in a reverse merger transaction on October 4, 2023.Oct 5, 2023 · SomaLogic ( SLGC) and Standard BioTools ( LAB) announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 ... SomaLogic Inc stock performance at a glance. Check SomaLogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. SLGCW Stock Performance. USD USD; Previous close: 0.1537: 0.1537: Day range: 0.1375 - 0.170.1375 - 0.17Year range: 0 - 00 - 0Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, market cap, beta, PE ratio, EPS and more. Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of 66.67%. The lowest target is $2.30 and the highest is $7.00. On average, analysts rate SomaLogic stock as a buy.SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...He currently serves as Chairman of SomaLogic, a company that he founded and formerly served as CEO. ... The most recent stock trade was executed by Asset Management Llp Oxford on 9 October 2019, trading 699,900 units of KBLM stock currently worth $7,355,949.Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …Somalogic stock

Appointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the …. Somalogic stock

somalogic stock

Information on stock, financials, earnings, subsidiaries, investors, and executives for SomaLogic. Use the PitchBook Platform to explore the full profile.SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. …Shares of SomaLogic have tracked along with them, due to the all-stock nature of the deal, bringing SomaLogic's market capitalization down to $354.7 million, essentially the amount of cash the firm had at the end of the second quarter. "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with …SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...Standard BioTools (LAB) will acquire SomaLogic Inc. (SLGC) in an all-stock deal. For each share of SomaLogic stock, shareholders will receive 1.11 shares of Standard BioTools stock. After the acquisition, SomaLogic shareholders will own about 57% of the combined company while 43% would be owned by Standard BioTools …Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...If you hold stock certificates in your name, please contact our transfer agent, Continental, at 1-877-634-5370. ... Does SomaLogic have a direct stock purchase plan? Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50. Oct. 05. MT. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29. hace 8 horas ... ... SomaLogic Investor Relations at [email protected]. No Offer or ... Stock Picks. More Stock Picks · 3 Dividend Stocks for December 2023.Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility, with coefficients of variation ~5%. Most protein assays excel in one or two areas. The SomaScan Assay is the first and only platform that enables 11,000 protein measurements from a 55-µL sample.Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …5 oct 2023 ... Somalogic shareholders will receive 1.11 shares of Standard BioTools' common stock for every share owned by SomaLogic. Standard Biotools ...Stockholder, Stake, Shares owned, Total value ($), Shares bought / sold, Total change. ARK Investment Management LLC, 6.88%, 12,983,002, 28,952,094 [email protected] look at Olink stock. 4.2 billion market cap. it may actually be the largest proteomic stock. they use aptamers like somalogic. Reply Like. h. highgrowthinvestment. 08 Aug. 2021.Nov 17, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for SomaLogic stock is Hold based on the current 3 hold ratings and 2 buy ratings for SLGC. The average twelve-month price prediction for SomaLogic is $4.26 with a high price target of $7.00 and a low price target of $2.30. Learn more on SLGC's analyst rating ... SomaLogic last released its earnings results on November 8th, 2023. The reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.05. The firm had revenue of $22.05 million for the quarter, compared to analysts' expectations of $20.45 million. SomaLogic has generated ($0.69) earnings per share over the last year ...common stock and SomaLogic preferred stock held in SomaLogic’s treasury or owned by the Company, Merger Sub or SomaLogic immediately prior to the Effective Time (each an “E x c l ude d Share”), will be cancelled and no consideration will be paid or payable with respect thereto and (ii) each share of SomaLogic stock, other thanStandard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...SomaLogic, Inc. (SLGC) delivered earnings and revenue surprises of 0% and 21.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]Oct 4, 2023 · SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ... SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the ...SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company. Business combination results in approximately $630 …Oct 4, 2023 · BOULDER — SomaLogic Inc. (Nasdaq: SLGC) and California-based Standard BioTools Inc. (Nasdaq: LAB) have agreed to an all-stock merger deal that is expected to result in a combined company valued at more than $1 billion. Existing executives with both companies will lead the combined organization, which will carry the Standard BioTools name. SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose - Unleashing tools to accelerate breakthroughs in humanGet the latest Somalogic Inc (SLGC) stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's financial performance, balance sheet, cash flow, and earnings per share for the fiscal Q2 2023 ended 6/30/23.Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the SUnder the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, SomaLogic …IPO & Stock Price. Edit IPO & Stock Price Section. SomaLogic is registered under the ticker FRA:76X0 . Stock Symbol FRA:76X0 ; IPO Date Sep 10, 2021; Stock chart by . Investors. ... SomaLogic has a post-money valuation in the range of $1B to $10B as of Jan 4, 2018, according to PrivCo.Stock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Real time SomaLogic (SLGC) stock price quote, stock graph, news & analysis. The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.Nov 29, 2023 · After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ... The average price point forecasted by analysts for SomaLogic Inc (SLGC) is $4.70, which is $2.18 above the current market price. The public float for SLGC is 152.97M, and currently, short sellers hold a 5.10% ratio of that floaft. The average trading volume of SLGC on November 15, 2023 was 1.50M shares. Top 5 AI Stocks to Buy for 2023.Oct 4, 2023 · SomaLogic Inc.'s (SLGC) stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with ... SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November 8, 2023, to discuss its third quarter 2023 financial results. Those interested in listening to the conference call should register online here.The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )View the latest SomaLogic Inc. (SLGC) stock price, news, historical charts, analyst ratings and financial information from WSJ.Standard BioTools Inc. and SomaLogic Inc. have agreed to merge in an all-stock deal to combine suppliers of tools to the medical research and drug development industry. The deal gives the combined ...Oct 4, 2023 · Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ... SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …Nov 22, 2023 · Why SomaLogic Stock Dived by 10% on Wednesday msn.com - October 4 at 6:56 PM: Shareholder Alert: Ademi LLP investigates whether SomaLogic, Inc. has obtained a Fair Price in its transaction with Standard BioTools benzinga.com - October 4 at 1:56 PM: SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Standard BioTools and SomaLogic will host a joint conference call and webcast today at 8:30 a.m. ET to discuss the merger. The conference call can be accessed by dialing (800) 225-9448 within the .... Sagafallabella